Clinical Trial Update: Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

View source ↗

Summary

A clinical trial update describes a prediction study for the SURPASS-CVOT cardiovascular outcome trial in type 2 diabetes using healthcare claims data. The SURP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes, Major Adverse Cardiac Events | Status: COMPLETED